Zogenix reported $77.33M in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 266.96M 37.53M
Adamas Pharmaceuticals ADMS:US 88.8M 36.03M
Aerie Pharmaceuticals AERI:US $ 79.96M 42.74M
Alnylam Pharmaceuticals ALNY:US $ 745.77M 366.22M
Arena Pharmaceuticals ARNA:US $ 514.18M 81.2M
AstraZeneca AZN:LN 15567M 7931M
Becton, Dickinson and BDX:US $ 3153M 581M
Biocryst Pharmaceuticals BCRX:US $ 218.43M 8.47M
Biogen BIIB:US $ 1742M 524.5M
Cardinal Health CAH:US 3.41B 92M
Esperion Therapeutics ESPR:US $ 219.19M 1.25M
Flexion Therapeutics FLXN:US $ 107.63M 8.92M
GlaxoSmithKline GSK:LN 3503M 1254M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Heron Therapeutics HRTX:US $ 191.17M 131.43M
Intra Cellular Therapies ITCI:US $ 121.03M 8.95M
Marinus Pharmaceuticals MRNS:US $ 112.49M 10.98M
Nektar Therapeutics NKTR:US $ 152.34M 2.18M
Neurocrine Biosciences NBIX:US $ 368M 15.4M
Revance Therapeutics RVNC:US $ 167.63M 81.79M
Sarepta Therapeutics SRPT:US $ 1697.28M 215.44M
Teva Pharmaceutical TEVA:IT 2.44B 693M
Zogenix ZGNX:US $ 77.33M 38.36M